Contingencies (Details) $ in Millions |
1 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
|
Feb. 05, 2019
USD ($)
|
Apr. 30, 2020
USD ($)
|
Apr. 16, 2019
USD ($)
|
Jul. 31, 2020
USD ($)
|
|
| Contingencies (Details) [Line Items] | ||||
| Number of pending cases | 2 | |||
| Contingencies approval, percent | 80.00% | |||
| Legal and related expenses | $ 0.8 | |||
| Litigation settlement, amount awarded from other party | $ 0.8 | |||
| Gain (Loss) related to litigation settlement | $ 19.4 | |||
| Description of one-time payments | The terms of the agreement include one-time payments totaling $14 million to the Company in exchange for fully paid-up, worldwide licenses to Hologic and Grifols. | |||
| Roche [Member] | ||||
| Contingencies (Details) [Line Items] | ||||
| Litigation settlement, amount awarded from other party | $ 21.0 | |||
| Hologic inc [Member] | ||||
| Contingencies (Details) [Line Items] | ||||
| Gain (Loss) related to litigation settlement | $ 9.5 | |||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount awarded from other party in judgment or settlement of litigation. No definition available.
|
| X | ||||||||||
- Definition Description of the nature and terms of commitment. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|